Universidad Complutense de Madrid-ko ikertzaileekin lankidetzan egindako argitalpenak (5)

2021

  1. An Fc-free EGFR-specific 4-1BB-agonistic trimerbody displays broad antitumor activity in humanized murine cancer models without toxicity

    Clinical Cancer Research, Vol. 27, Núm. 11, pp. 3167-3177

  2. DNGR-1 limits Flt3L-mediated antitumor immunity by restraining tumor-infiltrating type i conventional dendritic cells

    Journal for ImmunoTherapy of Cancer, Vol. 9, Núm. 5

  3. Preclinical evaluation of the safety and immunological action of allogeneic ADSC-collagen scaffolds in the treatment of chronic ischemic cardiomyopathy

    Pharmaceutics, Vol. 13, Núm. 8

2017

  1. Strategies to design clinical studies to identify predictive biomarkers in cancer research

    Cancer Treatment Reviews, Vol. 53, pp. 79-97

2004

  1. Inmunidad y terapia génica: Beneficios y riesgos

    Inmunologia, Vol. 23, Núm. 1, pp. 56-62